STE vs SYK
STE: STERIS is a global provider of infection prevention and procedural care products and services that help healthcare and life science organizations create a safer, healthier world. SYK: A diversified medical technology leader offering surgical equipment, orthopedic robotics, and minimally invasive neurovascular products that collectively serve over 150 million patients annually across 61 countries.
Side-by-side fundamentals
| Metric | STE | SYK | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $218.40 | $336.74 | |
| Market cap as of 2026-07-30 | $21.3B | $129.1B | |
| P/E as of 2026-07-30 | 29.16 | 40.36 | STE lower |
| PEG as of 2026-07-30 | 1.09 | 3.29 | STE lower |
| Net margin as of 2026-07-30 | +13.2% | +13.2% | SYK higher |
| Gross margin as of 2026-07-30 | +44.3% | +64.2% | SYK higher |
| Operating margin as of 2026-07-30 | +18.5% | +19.7% | SYK higher |
| ROE as of 2026-07-30 | +11.1% | +15.1% | SYK higher |
| ROA as of 2026-07-30 | +7.4% | +7.1% | STE higher |
| Debt / equity as of 2026-07-30 | 0.27 | 0.64 | STE lower |
| Revenue growth (YoY) as of 2026-07-30 | +8.7% | +8.8% | SYK higher |
| Revenue CAGR (3y) SEC XBRL | +9.4% | +10.8% | SYK higher |
| Dividend yield as of 2026-07-30 | +1.1% | +1.0% | STE higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-30 | 0.91 | 0.76 | |
| 1-year return as of 2026-07-27 close | -5.2% | -16.6% | STE higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.